Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants
Nawaid Usmani1, Nick Chng, Ingrid Spadinger
1Department of Oncology, University of Alberta, Edmonton, Alberta, Canada. nawaid.usmani@albertahealthservices.ca
Purpose:
Quantify the migration of iodine-125 RAPIDStrands ("strands") from Day 0 to Day 30 postoperatively in patients treated with prostate brachytherapy.
Methods And Materials:
Gold fiducial markers were inserted into the prostate before implants to serve as a fixed reference point within the prostate. Study patients underwent CT scans of the pelvis on Day 0 and Day 30 postimplant to image the prostate. In-house MATLAB software reconstructed each strand and determined its location relative to the center of mass of the fiducial markers. The recorded migration was taken to be the difference in these locations between Day 0 and Day 30.
Results:
A total of 232 strands containing 1069 sources were implanted in 10 patients. Overall, 84% of strands migrated by less than 5mm in any direction. The collection of strands were displaced a mean distance of +0.22mm laterally (95% confidence interval [CI]: +0.08 to +0.37mm), -0.22mm posteriorly (95% CI: -0.51 to +0.06mm), and +0.41mm superiorly (95% CI: +0.03 to +0.79mm). Strands located in the anterior prostate demonstrated the greatest degree of migration in any direction, moving a mean of +1.55mm superiorly. These strands also moved a mean distance of 0.84mm posteriorly, whereas posteriorly located strands moved by a mean distance of 0.82mm anteriorly, consistent with movement because of the resolution of edema.
Conclusions:
This study did not identify any clinically significant patterns of mean migration of iodine-125 RAPIDStrands from Day 0 to Day 30 postimplant.
More Related Videos
08:45Utilizing Custom-designed Galvanotaxis Chambers to Study Directional Migration of Prostate Cells
Published on: December 7, 2014
08:38Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
Related Concept Videos
07:23An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
07:01Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
05:32Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
08:45Utilizing Custom-designed Galvanotaxis Chambers to Study Directional Migration of Prostate Cells
08:38Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Fixing Double-strand Breaks
